- Case report
- Open Access
- Open Peer Review
Scar-like lesion on dorsal nose (cellular neurothekeoma)
© López-Cepeda et al; licensee BioMed Central Ltd. 2007
- Received: 13 February 2006
- Accepted: 30 November 2007
- Published: 30 November 2007
Neurothekeomas are tumors of neural differentiation and of unknown origin that occur in females at the 2nd and 3rd decades of life. They usually affect the face with an unspecific clinical aspect. The histological features include cellular or mixoid differentiation and immunohistochemistry can be positive for protein s-100, vimentin and epithelilal membrane antigen (EMA).
This case report presents a 13-year-old female patient with nasal neurothekeoma of cellular variety and strongly positive for vimentin and s-100; and negative for EMA.
- Glial Fibrillary Acidic Protein
- Myelin Basic Protein
- Neural Differentiation
- Alcian Blue
Neurothekeoma (NK) is a tumor of neural differentiation first described by Harkin and Reed in 1969  and later termed "neurothekeoma" by Gallager and Helwig in 1980 . Being extremely rare (1 of 4000 biopsies in international reports) , it is hitologically constituted by cellular proliferation arranged in lobules or fascicles immersed in an amorphous matrix in the dermis and rarely in subcutaneous tissue .
The origin of this tumor is unknown. Some authors consider it as Schwann cells,  while others state that perineural tissue or supporting structures of peripheric nerves, fibroblasts, and muscle could be responsible . It has even been considered as a variant of the following dermatoses: dermatofibroma , pilar epithelioid leiomioma , plexiform neurofibroma,  and nerve sheath myxoma .
NK presents frequently in females between 10–66 years (especially among the 2nd and 3rd decades of life). It is most commonly located is on the head, face and superior mid-body. To date, 21 reports have shown facial occurrence (with one patient revealing nasal manifestation) and 31 reports demonstrate occurrence of NK in patients younger than 20 years old [5, 9–11]. Other reports have documented different locations of occurrence including tongue , oral mucosa, eyelids , trunk (dorsum and shoulders) and superior extremities (superior mid body).
NK has an unspecific clinical aspect, more frequently presenting as a cupuliform, firm, flesh-colored or hyperpigmented papule-like formation which rarely exceeds 10 mm with capillaries on its surface and may be asymptomatic. The evolution varies between 18 months and 30 years; with a slowly growing, generally benign course.
Mucinous or myxoid: It is the most frequent form. It has an evident fascicular and tabicated aspect with abundant mucinous and amorphous substance, composed principally of acid mucopolysaccharides.
Cellular – epitheloid or fusiform cells with a cellular pattern and fascicle-nodular aggregation, circumscribed to reticular dermis, showing a grenz zone separating the dermis from the subacent tumor. There can be some mitotic figures , atypical features  and metachromasia with Giemsa stain . Collagen may be sclerotic with some lymphocytic infiltration. Barnhill, et al.  consider that the cellular neurothekeoma might be an early form (more frequent in young patients), whilethe mucinous type might represent a tumor of longer evolution (frequent in older patients).
NK is positive with alcian blue at pH 2.5, and there are reports of metachromasia with Giemsa stain .
By immunohistochemistry, protein S-100  has been found positive, as well as other stains: epithelilal membrane antigen (EMA), vimentin and neuron specific enolase (NSE), (with controversial results) . Other useful markers are: myelin basic protein, neurofilaments, glial fibrillary acidic protein (GFAP), keratin and Leu-7 , NK1/C3 and PGP9.5 [2, 16].
Immunohistochemistry was strongly positive for vimentin, lightly postitive for s-100, negative for EMA and positive for mucin. Based on biopsy and immunohistochemistry, the diagnosis of Neurothekeoma was made.
In the present case, clinical diagnosis of neurothekeoma was difficult to make since the lesion had a scar-like pattern, without previous history of trauma. Histological examination is definetely essential for the diagnosis, and must be interpreted by experienced dermatopathologists. An interesting feature of this case is that it was positive for both of the neurofilament stains (Bielchowsky) and mucin stain (Mucicarmin of Mayer) showing its dual differentiation: neural and myxoid.
Dr. Victor Jaimes, Dermatology Department, "Centro Médico Nacional 20 Noviembre, ISSSTE", for helping us obtain immunohistochemistry stains.
José Alberto Castillo Naranjo, Histotechnologist, "Centro Dermatológico Pascua", for the slides with special stains.
Dr. Maria del Mar Paola Campos Fernández, for her Assistance in writing the manuscript.
Written consent was obtained from the patient prior to submission of the manuscript.
- Del Río de la Torre E, Requema V: Neurotecoma (mixoma cutáneo de la vaina nerviosa). Estudio histopatológico de 4 casos. Piel. 1993, 8: 116-121.Google Scholar
- Gallager RL, Helwig EB: Neurothekeoma – a benign cutaneous tumor of neural origin. Am J Clin Pathol. 1980, 74: 759-64.View ArticlePubMedGoogle Scholar
- Watanabe K, Kusakabe T, Hoshi N, Suzuki T: Subcutaneous cellular neurothekeoma: a pseudosarcomatous tumor. Br J Dermatol. 2001, 144: 1273-1274. 10.1046/j.1365-2133.2001.04254.x.View ArticlePubMedGoogle Scholar
- Requena L, Sangüeza O: Benign neoplasms with neural differentiation: a review. Am J Dermatopathol. 1995, 17: 75-96.View ArticlePubMedGoogle Scholar
- Zelger BG, Steiner H, Kutzner H, Maier H, Zelger B: Cellular neurothekeoma: an epitheloid variant of dermatofibroma?. Histopathology. 1998, 32: 414-22. 10.1046/j.1365-2559.1998.00406.x. summaryView ArticlePubMedGoogle Scholar
- Calonje E, Wilson-Jones E, Smith NP, Fletcher CDM: Cellular Neurothekeoma: An epithelioid variant of pilar leiomioma? Analysis of series. J Cutan Pathol. 1991, 18: 363-Google Scholar
- Jurecka W: Nerve sheath myxoma: An immunohistochewmical study of a case. Dermatology. 1992, 184: 228-View ArticlePubMedGoogle Scholar
- Nagai Y, Ohno Y, Ishikawa O, Miyachi Y: Cellular neurothekeoma on the lower lip, letter. Br J Dermatol. 1997, 137: 314-315.PubMedGoogle Scholar
- Pepine M, Flowers F, Ramos-Caro F: Neurothekeoma in a 15 year old boy: case report. Pediatr Dermatol. 1992, 9: 272-274.View ArticlePubMedGoogle Scholar
- Penarrocha M, Bonet J, Minués JM, Vera F: Nerve sheath myxoma (neurothekeoma) in the tongue of a newborn. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000, 90: 74-7.View ArticlePubMedGoogle Scholar
- You TT, Kaiser PK, Netland TP, Jakobiec FA: Neurothekeoma palpebrae: a rare nerve sheath tumor arising the eyelid. Ophthal Plast Reconstr Surg. 1999, 15: 448-9.View ArticlePubMedGoogle Scholar
- Barnhill RL, Dickersin GR, Nickeleit V, Bhan AK, Muhlbauer JE, Philips ME, Mihm MC: Studies on the cellular origin of neurothekeoma: clinical, light microscopic, immunohistochemical and ultrastructural observations. J Am Acad Dermatol. 1991, 25: 80-88.View ArticlePubMedGoogle Scholar
- Busam KJ, Mentzel T, Colpaert C, Barnhilla RL, Fletcher CD: Atypical or worrisome features in cellular neurothekeoma: a study of 10 cases. Am J Surg Pathol. 1998, 22: 1067-72. 10.1097/00000478-199809000-00004.View ArticlePubMedGoogle Scholar
- Husain S, Silvers D, Halperin A, Mc Nutt NS: Histologic Spectrum of neurothekeoma and the value of immunoperoxidase staining for s-100 protein in distinguishing it from melanoma. Am J Dermatopathol. 1994, 16: 496-503.View ArticlePubMedGoogle Scholar
- Aronson P: Unmasking myelin proteins in neurothekeoma. Letter. 1992, 26: 659-Google Scholar
- Wang AR, May D, Bourne P, Scout G: PGP9.5: a marker for cellular neurothekeoma. Am J Surg Pathol. 1999, 23: 1401-7. 10.1097/00000478-199911000-00011.View ArticlePubMedGoogle Scholar
- Armed Forces Institute of Pathology: Manual of histologic and special staining technics. 1957, Washington D.CGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.